Orthogen, LLC

Nanogen and Dentogen Bone Grafts: Proven Effectiveness


Springfield, NJ -- (SBWIRE) -- 01/22/2016 -- Orthogen, LLC the developer of the NanoGen bone graft, is pleased to announce that a multi-center study on the efficacy of the NanoGen bone graft and the DentoGen bone graft was published in the highly reputed journal, Compendium. The study was run for four months and it monitored the results obtained using each product for grafting human extraction sockets. Sixty patients were recruited and designated to the groups. The study found that both products had excellent bone forming capacity, filling sockets to 76% on radiographic evaluation after four months.

The study, titled An Evaluation and Comparison of the Efficacy of Nanocrystalline Calcium Sulfate Bone Grafts (NanoGen) and Medical-Grade Calcium Sulfate Bone Grafts (DentoGen) in Human Extraction Sockets, monitored the effectiveness of both products up to 4 months. The mean percentage of actual bone formed by both products after 4 months was an impressive 51%. This was observed histologically. The conclusion of the study reads "both the materials investigated in the study showed excellent bone forming capacity, but the nanocrystalline version (NanoGen) of calcium sulfate was found to have clinical and biologic advantages over DentoGen".

The study in Compendium only proves what Orthogen and its customers know. Both NanoGen and DentoGen are truly impressive bone graft products, able to accomplish actual bone regeneration after extraction in the maxilla and the mandible.

Dental professionals who want to buy Orthogen's cutting-edge bone grafting dental materials can contact them at 1-877-336-8643. More information, including testimonials from dentists all across the world, can be seen on the Orthogen website at http://www.orthogencorp.com.

About Orthogen, LLC
Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications. Dr. Sachin Mamidwar serves as CEO of the company whereas Dr. Harold Alexander, previously Director of Orthopedic research at the Hospital for Joint Diseases, New York, serves as the Chairman of the Board. Orthogen offers various products including DentoGen®, NanoGen, collagen membranes, related instruments and sutures for dental applications.

To inquire about the company's products and technologies, please call 1-877-336-8643.